Transgenic models in renal tubular physiology

Experimental Nephrology

Volumn 6, Issue 5, 1998, Pages 438-446

  Jaisser, Frederic ^a   Beggah, Ahmed T ^a  

^a INSERM   (France)

Author keywords

Biological sciences; Conditional transgene expression; Homologous recombination; Physiology; Transgenesis

Indexed keywords

AMILORIDE; AQUAPORIN; SODIUM ION; TRANSCRIPTION FACTOR;

ANIMAL CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; DIAGNOSTIC APPROACH ROUTE; GENE MUTATION; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE CELL; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATOR GENE; REVIEW; TRANSGENIC MOUSE;

EID: 0031700907     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020553     Document Type: Review

References (52)

1. Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH: Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci USA 1980;77:7380-7384.
2. Kitamura M (ed): Genetic manipulation of the kidney. Exp Nephrol 1997;5:109-173.
3. Davisson RL, Sigmund CD: Transgenic animal models as tools for studying renal developmental physiology. Pediatr Nephrol 1996;10: 798-803.
4. Kopp JB, Klotman PE: Transgenic animal models of renal development and pathogenesis. Am J Physiol 1995;269:F601-F620.
5. Babinet C, Morello D, Renard JP: Transgenic mice. Genome 1989;31:938-949.
6. Bronson SK, Smithies O: Altering mice by homologous recombination using embryonic stem cells. J Biol Chem 1994;269:27155-27158.
7. Hogan B, Beddington R, Costantini F, Lacy E: Manipulating the Mouse Embryo, ed 2. Plain-view, Cold Spring Harbor Laboratory Press, 1994.
8. Trudel M, D'Agati V, Costantini F: C-myc as an inducer of polycystic kidney disease in transgenic mice. Kidney Int 1991;39:665-671.
9. Nakayama K, Nakayama K, Negishi I, Kuida K, Sawa H, Loh DY: Targeted disruption of Bcl-2 alpha beta in mice: Occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci USA 1994;91: 3700-3704.
10. Schaffner DL, Barrios R, Massey C, Banez EI, Ou CN, Rajagopalan S, Aguilar-Cordova E, Lebovitz RM, Overbeek PA, Lieberman MW: Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys. Am J Pathol 1993;142:1051-1060.
11. Stocklin EF, Botteri F, Groner B: An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice. J Cell Biol 1993; 122:199-208.
12. Briand P, Kahn A, Vandewalle A: Targeted oncogenesis: A powerful method to derive renal cell lines (editorial). Kidney Int 1995;47: 388-394.
13. Gabow PA: Autosomal dominant polycystic kidney disease. N Engl J Med 1993;329:332-342.
14. Geng L, Zhang F, Schneider MC, Pohlscmidt M, Zhou J, Zhao H, Torosian S, Lohning C, Kovats S, Frischauf AM, Fu YH, Reeders ST: Gene structure, sequence, and point mutation in the PKD1 gene, and search for point mutations. J Am Soc Nephrol 1994;4:622.
15. Lu W, Peissel B, Babakhanlou H, Pavlova A, Geng L, Fan X, Larson C, Brent G, Zhou J: Perinatal lethality with kidney and pancreas defects in mice with a targeted Pkd1 mutation. Nat Genet 1997;17:179-181.
16. Hummler E, Barker P, Gatzy J, Beermann F, Verdumo C, Schmidt A, Boucher R, Rossier BC: Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice. Nat Genet 1996;12:325-328.
17. Hummler E, Barker P, Talbot C, Wang Q, Verdumo C, Grubb B, Gatzy J, Burnier M, Horisberger JD, Beermann F, Boucher R, Rossier BC: A mouse model for the renal salt-casting syndrome pseudohypoaldosteronism. Proc Natl Acad Sci USA 1997;94:11710-11715.
18. Kuro-o M, Hanaoka K, Hiroi Y, Noguchi T, Fujimori Y, Takewaki S, Hayazaka M, Katoh H, Miyagishi A, Nagai R, Yazaki Y, Nabeshima Y: Salt-sensitive hypertension in transgenic mice overexpressing Na(+)-proton exchanger. Circ Res 1995;76:148-153
19. Schultheis PJ, Clarke LL, Meneton P, Miller MI, Soleimani M, Gawenis LR, Riddle TM, Duffy JJ, Doetschman JL, Wanf T, Giebisch G, Aronson PS, Lorenz JN, Shull GE: Renal and intestinal absorptive defects in mice lacking the NHE3 Na+/H+ exchanger. Nat Genet 1998;19(3):282-285.
20. + exchanger isoform 2 gene causes reduced viability of gastric parietal cells and loss of net acid secretion. J Clin Invest 1998;101:1243-1253.
21. Geering K: Subunit assembly and functional maturation of Na,K- ATPase. J Membr Biol 1990;115:109-121.
22. Courtois-Coutry N, Roush D, Rajendran V, McCarthy JB, Geibel J, Kashgarian M, Caplan MJ: A tyrosme-based signal targets H/K-ATPase to a regulated compartment and is required for the cessation of gastric acid secretion. Cell 1997;90:501-510.
23. Wang T, Courtois-coutry N, Giebisch GH, Caplan MJ: tyrosine- based signal in the cytoplasmic tail of the H,K-ATPase β-subunit modulates potassium resorption in the kidneys of transgenic mice (abstract). J Am Soc Nephrol 1997;8.46.
24. + deprivation in colonie H,K-ATPase-deficient mice. J Clin Invest 1998;101.536-542.
25. Jaisser F, Beggah AT: The X,K-ATPases: Molecular and functional properties. Am J Physiol 1998, in press.
26. +-ATPase in the kidney: Localization and function in the nephron. Exp Nephrol 1997;5:271-276.
27. Knepper MA, Verbalis JG, Nielsen S: Role of aquaporins in water balance disorders. Curr Opin Nephrol Hypertens 1997;6:367-371.
28. Ma T, Yang B, Verkman AS: Generation of embryonic stem cell and mouse germ lines for AQP1 knock-out (abstract). J Am Soc Nephrol 1997;8:21.
29. Ma T, Yang B, Gillespie A, Carlson J, Epstein CJ, Verkman AS: Generation and phenotype of a transgenic knockout mouse lacking the mercurial-insensitive water channel aquaporin-4. J Clin Invest 1997;100:957-962.
30. Pontoglio M, Barra J, Hadchouel M, Doyen A, Kress C, Bach JP, Babinet C, Yaniv M. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 1996;84:575-585.
31. 31a Robine S, Jaisser F, Louvard D: Epithelial cell growth and differentiation. IV. Controlled spatiotemporal expression of transgenes: New tools to study normal and pathological states. Am J Physiol 1997;273:G759-G762.
32. 31b Cohen-Tannoudji M, Robine S, Choulika A, Pinto D, El Marjou F, Babinet C, Louvard D, Jaisser P: I-SceI-mduced gene replacement at a natural locus in embryonic stem cells. Mol Cell Biol 1998;18(3):1444-1448.
33. Furth PA, St Onge L, Boger H, Gruss P, Gossen M, Kistner A, Bujard H: Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 1994;91:9302-9306.
34. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lubbert H, Bujard H: Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996;93:10933-10938
35. Gossen M, Bujard H: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992;89:5547-5551.
36. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H: Transcriplional activation by tetracyclines in mammalian cells. Science 1995;268:1766-1769.
37. Rossant J, Nagy A: Genome engineering: the new mouse genetics. Nat Med 1995;1:592-594.
38. Rajewsky K, Gu H, Kuhn U, Bett A, Muller W, Roes J, Schwenk F: Conditional gene targeting. J Clin Invest 1996;98:600-603.
39. Zhang Y, Riesterer C, Ayrall AM, Sablitzky F, Littlewood TD, Reth M: Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res 1996;24:543-548.
40. Efrat S, Fusco-DeMane D, Lemberg H, al Emran O, Wang X: Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci USA 1995;92: 3576-3580.
41. Yu Z, Redfern CS, Fishman GI: Conditional transgene expression in the heart. Circ Res 1996;79:691-697.
42. Mayford M, Bach ME, Huang YY, Wang L, Hawkins RD, Kandel ER: Control of memory formation through regulated expression of a CaMKII transgene. Science 1996;274:1678-1683.
43. Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K: Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting (see comments). Science 1994;265:103-106.
44. Lakso M, Sauer B, Mosinger B, Lee EJ, Manning RW, Yu SH, Mulder KL, Westphal H: Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci USA 1992;89:6232-6236.
45. Kellendonk C, Tronche F, Monaghan AP, Angrand PO, Stewart F, Schutz G: Regulation of Cre recombinase activity by the synthetic steroid RU 486. Nucleic Acids Res 1996;24: 1404-1411.
46. Metzger D, Clifford J, Chiba H, Chambon P: Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc Natl Acad Sci USA 1995;92:6991-6995.
47. Brocard J, Warot X, Wendling O, Messaddeq N, Vonesch JL, Chambon P, Metzger D: Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proc Nat Acad Sci USA 1997;94:14559-14563.
48. Schwenk F, Kuhn R, Angrand PO, Rajewsky K, Stewart AF: Temporally and spatially regulated somatic mutagenesis in mice. Nucleic Acids Res 1998;26:1427-1432.
49. Saito A, Yamazaki H, Nakagawa Y, Arakawa M: Molecular genetics of renal diseases. Intern Med 1997;36:81-86.
50. Bruce LJ, Cope DL, Jones GK, Schofield AE, Burley M, Povey S, Unwin RJ, Wrong O, Tanner MJ: Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J Clin Invest 1997;100:1693-1707.
51. Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP: Banter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 1996;13:183-188.
52. + channel, ROMK. Nat Genet 1996;14: 152-156.